http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150121265-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d22b649c54d79d7c1eabf23085b14a3e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0016 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-102 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate | 2014-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d84fb80aee391202086db44dda1289b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61547fc4017d57bf2935d6a279c66165 |
| publicationDate | 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20150121265-A |
| titleOfInvention | Method of treatment |
| abstract | (A) a bacterial saccharide (s) comprising at least one, two or three bacterial saccharide (s), each conjugated to a carrier protein to form at least one, two or three bacterial saccharide conjugates Immunizing a human patient of age 1 between 0 and 11 months with a saccharide conjugate vaccine; And b) N. meningitidis serogroup A capsular saccharide (MenA), N. meningitidis serogroup C capsular saccharide (MenC), N. meningitidis serogroup W135 capsular saccharide (MenW135 ), And N. meningitidis serogroup Y capsular saccharide (MenY), with a Nacelia meningitidis conjugate vaccine comprising at least two capsular saccharides selected from the group consisting of A method of immunizing a nephellium meningitidis infection, comprising the step of immunizing a human patient, wherein the nephelizer meningitidis conjugated vaccine is co-administered with a vaccine comprising diphtheria toxoid and tetanus toxoid. |
| priorityDate | 2013-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.